Cargando…
Generation of a High-Affinity Nanobody Against CD147 for Tumor Targeting and Therapeutic Efficacy Through Conjugating Doxorubicin
CD147, a glycosylated transmembrane protein in the immunoglobulin superfamily, is overexpressed on the surfaces of various tumor cells and promotes cancer cell proliferation, invasion, and metastasis. Nanobodies, characterized by small sizes, high affinities and specificities, and low immunogeniciti...
Autores principales: | Li, Rifei, Zhu, Xinjie, Zhou, Peng, Qiao, Yuehua, Li, Yinqian, Xu, Yice, Shi, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114487/ https://www.ncbi.nlm.nih.gov/pubmed/35603157 http://dx.doi.org/10.3389/fimmu.2022.852700 |
Ejemplares similares
-
Generation of high affinity ICAM-1-specific nanobodies and evaluation of their suitability for allergy treatment
por: Zettl, Ines, et al.
Publicado: (2022) -
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
por: Bannas, Peter, et al.
Publicado: (2017) -
Role of CD147 in the development and diagnosis of hepatocellular carcinoma
por: Huang, Defa, et al.
Publicado: (2023) -
Differential CD147 Functional Epitopes on Distinct Leukocyte Subsets
por: Pata, Supansa, et al.
Publicado: (2021) -
Applications of nanobodies in brain diseases
por: Zheng, Fang, et al.
Publicado: (2022)